Tuesday, November 18, 2014 10:52:02 PM
Bacterin Receives Delisting Notice From NYSE MKT
BELGRADE, Mont., Nov. 14, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE) today announced that the Company received notice that the staff of NYSE Regulation, Inc. has determined to commence proceedings to delist the Company's common stock from the NYSE MKT LLC ("NYSE MKT" or the "Exchange") because the Company did not cure its non-compliance with Sections 1003(a)(i), (ii) and (iii) of the NYSE MKT Company Guide by the end of the maximum 18 month compliance plan period, which expired on November 13, 2014. Therefore, the Company's common stock is subject to delisting from the Exchange.
The Company plans to appeal the delisting determination. The Company's common stock will continue to trade on the NYSE MKT pending the appeal and final determination by the hearing panel.
Recent XTNT News
- Xtant Medical Announces Launch of SimpliGraft™ and SimpliMax™ for Chronic and Acute Wounds • GlobeNewswire Inc. • 04/30/2024 09:00:00 AM
- Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million • GlobeNewswire Inc. • 04/01/2024 11:00:00 AM
- Xtant Medical to Issue Fourth Quarter and Full Year 2023 Financial Results on April 1, 2024 • GlobeNewswire Inc. • 03/21/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 10:13:22 PM
- Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial • GlobeNewswire Inc. • 03/07/2024 09:05:00 PM
- Xtant Medical to Present at the TD Cowen 44th Annual Healthcare Conference • GlobeNewswire Inc. • 02/26/2024 09:05:00 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 02/16/2024 09:05:39 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 10:10:19 PM
- Xtant Medical to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 02/05/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 09:11:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 09:42:41 PM
- Xtant Medical to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 11/09/2023 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 12:15:30 PM
- Xtant Medical Announces Record Third Quarter Revenue of $25 Million • GlobeNewswire Inc. • 11/09/2023 12:00:00 PM
- Xtant Medical to Issue Third Quarter 2023 Financial Results on November 9, 2023 • GlobeNewswire Inc. • 11/02/2023 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2023 09:00:32 PM
- Xtant Medical Announces Acquisition of nanOss Production Operations from RTI Surgical • GlobeNewswire Inc. • 10/23/2023 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/17/2023 08:43:14 PM
- Xtant Medical Highlights Growing Product Portfolio at NASS 2023 • GlobeNewswire Inc. • 10/12/2023 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/18/2023 08:15:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/17/2023 09:20:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/17/2023 09:11:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/17/2023 09:01:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/17/2023 08:46:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/17/2023 08:38:39 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM